Heart News and Research

RSS

Review shows lecanemab and donanemab slow decline and explains who should get them

The Lancet review synthesises evidence on anti beta amyloid monoclonal antibodies and the wider Alzheimer’s care pathway, weighing efficacy, safety, economics, and health system readiness across disease, patient, and population perspectives.

24 Sep 2025

Global cancer cases and deaths expected to soar by 2050 despite advances in treatment

There has been a rapid increase in the global number of cancer cases and deaths between 1990 and 2023, despite advances in cancer treatment and efforts to tackle cancer risk factors over that same time period.

24 Sep 2025

NIH awards $3.4 million to support research on Crimean-Congo hemorrhagic fever virus

Crimean-Congo hemorrhagic fever virus, or CCHFV, is a biosafety level 4 pathogen and a Category A bioterrorism agent, causing severe viral hemorrhagic fever with mortality rates reaching up to 40%.

24 Sep 2025

Developing a wearable device to track deadly postpartum hemorrhage

In the delivery room, circumstances can turn dire on a dime if the patient starts losing excessive amounts of blood. One minute she seems fine, and the next, vital signs plummet, the patient crashes, and the care team may need to scramble for a blood transfusion or perform surgery.

24 Sep 2025

Lipoprotein(a) testing remains uncommon in the United States

Researchers from University of California San Diego School of Medicine have found that testing for lipoprotein(a) - a genetic risk factor for heart disease - remains uncommon in the United States, despite modest increases over the past decade.

24 Sep 2025

Scientists show for the first time how fibroblasts go 'rogue' in different diseases

Scientists have mapped underappreciated scaffolding cells in skin, known as fibroblasts. They show for the first time how fibroblasts go 'rogue' in many different diseases affecting multiple organs – from acne and psoriasis, to rheumatoid arthritis and inflammatory bowel disease.

24 Sep 2025

Uncontrolled hypertension claims more than 10 million lives every year

The World Health Organization (WHO) today released its second Global hypertension report, showing that 1.4 billion people lived with hypertension in 2024, yet just over one in five have it under control either through medication or addressing modifiable health risks.

24 Sep 2025

Trump claims ‘no downside’ to avoiding Tylenol during pregnancy. He’s wrong.

Obstetricians have long advised their pregnant patients that Tylenol is the safest option to reduce fever or pain. President Donald Trump stood before a national audience on Sept. 22 and contradicted that.

24 Sep 2025

New research brings safer artificial hearts closer to clinical use

Using magnetic cameras, researchers at Linköping University have examined blood flow in an artificial heart in real time. The results make it possible to design the heart in a way to reduce the risk of blood clots and red blood cells breakdown, a common problem in today's artificial hearts.

24 Sep 2025

New recommendations aim to identify children with familial hypercholesterolemia

The Family Heart Foundation, a leading research and advocacy organization, announced the online publication of recommendations from a multidisciplinary panel in the Journal of Pediatrics to promote the early identification of children living with familial hypercholesterolemia (FH).

23 Sep 2025

Frequent exercise reshapes nerves that control the heart, research shows

Frequent exercise doesn't just strengthen the heart – it also changes the nerves that control it, according to new research which could guide more targeted and effective care for common heart problems.

23 Sep 2025

Fat distribution appears to influence cancer risk

How fat is distributed in people's bodies could make a difference to their risk of certain cancers, according to new research led by the University of Bristol. The international study is published in the Journal of the National Cancer Institute (JNCI) today [24 September].

23 Sep 2025

Alcohol-related mortality in the US surged 89% since 1999

A national study reveals a sharp rise in alcohol-induced deaths during COVID-19, with women and Native communities facing the greatest impact.

23 Sep 2025

Researchers call for consistent biomarker scoring

More than 1500 persons in Norway have had a liver transplantation. But how can doctors know which patients need extra follow-up or additional treatment so that as many as possible can live a long life afterwards?

23 Sep 2025

Orforglipron pill improves heart and metabolic risk factors in trial

Patients taking an experimental oral GLP-1 drug lost significant weight and improved their heart and metabolic risk factors in a large, international, phase 3 clinical trial led by investigators at Weill Cornell Medicine, McMaster University, York University and other institutions.

22 Sep 2025

Gut microbial imbalance linked to chronic sickle cell disease pain

A research collaboration involving scientists and students at The University of Texas at Dallas has found a clear connection between chronic sickle cell disease pain and the bacteria present in the gastrointestinal tract.

22 Sep 2025

Scientists use blood chemistry to predict disease years before it strikes

Researchers built the largest plasma metabolome-phenome atlas using 274,241 UK Biobank participants, linking over 73,000 metabolite-trait and 52,000 metabolite-disease associations. The study shows metabolic risk scores can predict diseases years before diagnosis, with strong accuracy for diabetes and kidney complications.

22 Sep 2025

New dialysis filter shows promise for improving survival and health in kidney failure patients

Researchers at London Health Sciences Centre Research Institute (LHSCRI) and Western University's Schulich School of Medicine & Dentistry have launched a clinical trial that is evaluating a new type of dialysis filter called Elisio HX that may significantly improve outcomes for people living with kidney failure across Canada.

22 Sep 2025

Psychological distress after a heart attack emerges as a critical risk factor for heart health

Many people experience one or more types of psychological distress, including depression, anxiety, psychosocial stress or post-traumatic stress disorder (PTSD), after a heart attack, which can affect their physical recovery and long-term heart health, according to a new American Heart Association scientific statement, published today in the American Heart Association's flagship, peer-reviewed journal Circulation.

22 Sep 2025

Yokogawa and Repligen partner to enhance process analytical technology

Yokogawa Corporation of America and Repligen announce a collaboration to integrate Yokogawa's OpreX Bio Pilot with Repligen's MAVERICK®, enhancing automated control of glucose and lactate levels in cell cultures.

22 Sep 2025